Patient Lifestyle

Canadian provinces and territories are now making 4th doses available. NACI recommends the booster dose for eligible at-risk patients over 70 years of age, however provincial eligibility varies and often includes those 60 years and older.

Dr. Robert Dickson found himself reminded recently of the importance of knowing the limits of one’s medical care.

International research indicates barrier-free contraceptives are an inexpensive way to improve overall health and come with cost savings over the long term.

But many are helpful for second-, third-line treatment courses.

Despite its prevalence, those living with the disease often wait an average of 7.5 years between start of symptoms and diagnosis.

Acuvue Theravision with Ketotifen is the first daily disposable contact lens that corrects vision and relieves ocular itch caused by allergic conjunctivitis.

When I was in grad school, a professor spoke with us about how our society doesn’t end things well—we’d rather say “see you later” than “this is goodbye.”

Study shows sustained effects, improved function, health status